Author:
Tsukada Chiharu,Saito Takahiro,Maekawa Masamitsu,Mano Nariyasu,Oda Akifumi,Hirasawa Noriyasu,Hiratsuka Masahiro
Funder
Ministry of Health, Labour and Welfare
Smoking Research Foundation
Japan Research Foundation for Clinical Pharmacology
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference35 articles.
1. Human CYP2C8: structure, substrate specificity, inhibitor selectivity, inducers and polymorphisms;Lai;Curr Drug Metab,2009
2. PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8;Aquilante;Pharmacogenet Genomics,2013
3. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid;Dai;Pharmacogenetics,2001
4. Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro;Yu;Biopharm Drug Dispos,2013
5. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5;Kaspera;Biochem Pharmacol,2011
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献